The new Code has been updated to reflect changes in the pharma environment The Association of the British Pharmaceutical Industry (ABPI) has launched its new Code of Practice, containing updated ...
Iain Shield (Associate Director – Market Access, Mtech Access) has reviewed the changes to the ABPI Code of Practice, and highlights updates to prescribing information (Clause 12) and considerations ...
For over 60 years the ABPI Code of Practice has been key to the UK industry’s self-regulation, and now, as pharma is experiencing its most intense period of change in decades, a new update seeks to ...
The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical ...
Novo Nordisk has been suspended from the Association of the British Pharmaceutical Industry (ABPI) due to what the organisation describes as ‘serious breaches’ of its code of practice. The decision ...
The Association of the British Pharmaceutical Industry has launched a public consultation on a “new-look, more user friendly” Code of Practice. The Code is designed to help govern the pharma ...
More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...
The body representing the UK pharma industry has published a draft 2021 code of practice, and is asking for feedback on the changes by 8 September. The Association of the British Pharmaceutical ...
The Association of the British Pharmaceutical Industry is consulting on its proposed Code of Practice for 2021, which supports industry to operate in a professional, ethical and transparent manner.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results